The Damage Profile Nobody Prepares You For.
Military service leaves a specific pattern of cumulative damage: joints ground down by years of rucking under load. Spines compressed by heavy kit. Hearing damaged by weapons fire and blast exposure. Sleep architecture shattered by deployment schedules. Chronic pain from injuries that were taped up and pushed through.
The VA treats each symptom separately: orthopedics for the knees, audiology for the hearing, psychiatry for the sleep and mood issues. Nobody connects the dots. Nobody addresses the systemic inflammatory state that ties all of it together.
Peptides offer what the fragmented VA system does not: a protocol that addresses multiple damage vectors simultaneously through shared biological pathways. Inflammation reduction, tissue repair, neurological support, and sleep restoration—the common threads running through every veteran health complaint.
Joint and Connective Tissue: The Rucking Tax.
Years of marching and running under 60-100 lb loads create a specific injury pattern: accelerated cartilage degeneration in knees and ankles, lumbar disc compression, and chronic tendinopathy in load-bearing structures.
BPC-157 is the first-line peptide for this damage. Its tendon repair research directly addresses the connective tissue degeneration from sustained mechanical overload. Subcutaneous administration near the most affected joints supports local tissue repair.
TB-500 provides systemic anti-inflammatory and tissue repair coverage for veterans with multi-joint involvement. When the damage is in your knees, ankles, hips, and back simultaneously, TB-500's systemic distribution addresses all of it without requiring separate injection targeting.
GHK-Cu for long-term collagen remodeling. The scar tissue and fibrosis accumulated over years of service can be actively remodeled with consistent GHK-Cu protocols.
Typical protocol: BPC-157 500 mcg subcutaneous twice daily (rotate between most affected joints) + TB-500 2 mg twice weekly + GHK-Cu 1 mg daily. Run 12-16 week initial protocols.
Blast TBI and Cognitive Recovery.
The VA estimates 430,000+ service members sustained TBI during the Iraq and Afghanistan conflicts. Blast TBI creates diffuse axonal injury—widespread neural damage without the focal impact pattern of sports concussions.
Cerebrolysin provides neurotrophic factor support for neural repair. Semax delivers BDNF upregulation and dopaminergic recovery. BPC-157 addresses the gut-brain axis dysfunction common in TBI patients.
The veteran TBI protocol follows the same framework as the concussion article but accounts for the diffuse nature of blast injury: longer protocol durations, more Cerebrolysin cycles, and concurrent Selank for the hypervigilance and anxiety components that accompany blast TBI.
See the full TBI protocol article for detailed dosing and phasing.
Hearing Damage.
Tinnitus is the #1 VA disability claim. Noise-induced hearing loss from weapons fire, explosions, and vehicle/aircraft noise affects the majority of combat veterans.
Peptide research for hearing is emerging. BPC-157 showed 35% faster auditory recovery in ototoxicity models. Cerebrolysin, already in the TBI protocol, contains neurotrophic factors relevant to auditory nerve repair. ACTH4-10 (a fragment of adrenocorticotropic hormone related to Semax) showed tinnitus symptom reduction in early studies.
This is a frontier application—clinical trials are in early phases and no peptide is established treatment for hearing loss. But for veterans managing tinnitus alongside TBI and chronic pain, the neuroprotective peptides in their existing protocol may provide secondary auditory benefits.
Sleep Architecture Reconstruction.
Deployment-disrupted sleep patterns do not automatically reset when you come home. Many veterans report persistent sleep dysfunction years after service—difficulty falling asleep, fragmented sleep, inability to reach deep sleep phases, and hyperarousal-driven insomnia.
DSIP (Delta Sleep-Inducing Peptide) promotes delta wave sleep architecture without sedation. Unlike sleep medications (which suppress rather than restore natural sleep patterns), DSIP supports the biological sleep process your deployments disrupted.
For veterans with hypervigilance-driven insomnia, Selank (GABA/serotonin modulation) addresses the neurochemical hyperarousal that keeps the sympathetic nervous system running hot at night.
Combination: DSIP 100-250 mcg subcutaneous before bed + Selank 250 mcg intranasal in the evening. Start 5-7 days before expecting significant improvement—both peptides build effects over time.
The PCAC Moment.
The July 23-24, 2026 PCAC meeting reviewing BPC-157, TB-500, KPV, MOTS-C, DSIP, Epitalon, and Semax is particularly significant for veterans. These are the compounds most relevant to service-connected health conditions.
The veteran community submitted the most public comments to the PCAC docket of any group. The lived experience data from service members has real weight in the advisory process.
A favorable vote would create a pathway from research peptides to physician-prescribed, pharmacy-compounded peptides. For veterans in the VA system, this could eventually mean TRICARE-covered peptide therapy prescribed by VA physicians. That timeline is years out even in the best case, but the regulatory foundation starts here.
Public comment deadline: July 9, 2026. Docket FDA-2025-N-6895 on regulations.gov. If peptides have made a difference in your post-service health, documented accounts matter.
◆ Key Takeaway
Military service creates a specific multi-system damage pattern: joint degeneration from load bearing, blast TBI, hearing loss, and sleep disruption. BPC-157 + TB-500 for musculoskeletal damage. Cerebrolysin + Semax for TBI/cognitive recovery. DSIP + Selank for sleep architecture. The July 2026 PCAC meeting could create a pathway to regulated veteran access to these compounds.